Notably, MCM1 is the downstream target of the mitogen-activated protein kinase (MAPK) pathway (50), which is the pathway most involved in SKCM, suggesting that MCM1 may play a role in melanoma tumorigenesis. The gene discussed is SRF; the disease is melanoma.